======= COMMD5 ======= == Gene Information == * **Official Symbol**: COMMD5 * **Official Name**: COMM domain containing 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=28991|28991]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9GZQ3|Q9GZQ3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608216|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). Negatively regulates cell proliferation. Negatively regulates cell cycle G2/M phase transition probably by transactivating p21/CDKN1A through the p53/TP53-independent signaling pathway. Involved in kidney proximal tubule morphogenesis (By similarity). Down-regulates activation of NF-kappa-B (PubMed:15799966). {ECO:0000250|UniProtKB:Q9ERR2, ECO:0000269|PubMed:15799966, ECO:0000305|PubMed:21778237}. |HCaRG| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.89| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.83| |[[:results:exp79|Q15 2.7μM R02 exp79]]|-2.76| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.57| |[[:results:exp483|FTY720 3μM R08 exp483]]|-2.55| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-2.55| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-2.3| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.27| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.27| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.23| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-2.23| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.01| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.98| |[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.86| |[[:results:exp433|LJH685 50μM R08 exp433]]|-1.82| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-1.78| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|-1.77| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.76| |[[:results:exp183|IU1-C 25μM R04 exp183]]|-1.73| ^Gene^Correlation^ |[[:human genes:c:ccdc22|CCDC22]]|0.688| |[[:human genes:a:arpc2|ARPC2]]|0.672| |[[:human genes:a:arpc4|ARPC4]]|0.646| |[[:human genes:a:actr3|ACTR3]]|0.618| |[[:human genes:c:commd3|COMMD3]]|0.613| |[[:human genes:c:commd2|COMMD2]]|0.594| |[[:human genes:v:vps29|VPS29]]|0.56| |[[:human genes:c:commd7|COMMD7]]|0.544| |[[:human genes:c:commd9|COMMD9]]|0.536| |[[:human genes:c:commd8|COMMD8]]|0.51| |[[:human genes:c:commd10|COMMD10]]|0.5| |[[:human genes:k:kiaa0196|KIAA0196]]|0.499| |[[:human genes:a:actr2|ACTR2]]|0.491| |[[:human genes:r:rab7a|RAB7A]]|0.471| |[[:human genes:c:ccdc53|CCDC53]]|0.46| |[[:human genes:l:lipa|LIPA]]|0.444| |[[:human genes:l:lzic|LZIC]]|0.438| |[[:human genes:c:c16orf62|C16orf62]]|0.43| |[[:human genes:c:chka|CHKA]]|0.426| |[[:human genes:v:vps35|VPS35]]|0.424| |[[:human genes:c:commd4|COMMD4]]|0.424| |[[:human genes:m:mtmr9|MTMR9]]|0.412| |[[:human genes:k:kiaa1033|KIAA1033]]|0.41| |[[:human genes:u:usp32|USP32]]|0.403| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8264 * **Expression level (log2 read counts)**: 1.9 {{:chemogenomics:nalm6 dist.png?nolink |}}